Serum from hemodialysis patients inhibits basal and cytokine-stimulated tissue factor expression in vitro

Journal of the American Society of Nephrology

Volumn 10, Issue 11, 1999, Pages 2403-2406

  Maderna, Paola ^b   Coleman, Patrick ^b   Godson, Catherine ^b   O'Meara, Yvonne M ^b   Brady, Hugh R ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; CYTOKINE; HEPARIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM; SERUM;

EID: 0032736864     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Wolley AC: Platelet dysfunction in uremia. Kidney Int 19: 15-20, 1987
2. Livio M, Benigni A, Remuzzi G: Coagulation abnormalities in uremia. Semin Nephrol 5: 82-90, 1985
3. Vaziri ND, Gonzales EC, Wang J, Said S: Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: Effect of hemodialysis. Am J Kidney Dis 23: 828-835, 1994
4. Connolly JE, Brownell DA, Levine ET, McCart PM: Complications of renal dialysis access procedure. Arch Surg 119: 1325-1328, 1994
5. Semeraro N, Colucci M: Tissue factor in health and disease. Thromb Haemost 78: 759-764, 1997
6. Lopez-Pedrera C, Jardí M, Ingles-Esteve J, Muñoz-Canoves P, Dorado G. Velasco F, Felez J: Characterization of tissue factor expression on the human endothelial cell line ECV304. Am J Hematol 56: 71-78, 1997
7. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
8. Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP: The lipoprotein-associated coagulation inhibitor that inhibits factor Xa: Insight into its possible mechanism of action. Blood 71: 335-343, 1998
9. Kario K, Matsuo T, Yamada T, Matsuo M: Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis. Thromb Haemost 71: 275-279, 1994
10. Malyszko J, Malyszko JS, Mysliwiec M: Tissue factor pathway inhibitor and tissue factor in HD and CAPD. Nephrol Dial Transplant 13: 2424-2425, 1998
11. Sandset PM, Abildgaard U, Larsen ML: Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res 50: 803-813, 1988
12. Novotny WF, Palmier M, Wun TC, Broze GJ Jr, Miletich JP: Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood 78: 394-398, 1991